Date of dispatch of this notice: 27/05/2022
Expire date: 27/06/2022
External Reference: 2022-217061
TED Reference: 2022/S 105-292961
Contract notice
Information
Published
Contract notice
Contract notice
Directive 2014/24/EU
Section I: Contracting authority
I.1)
Name and addresses
National Institute for Bioprocessing Research & Training (NIBRT)
IE6433711D
Fosters Avenue, Mount Merrion, Blackrock
Dublin
Co. Dublin
IE
Contact person:
Karl Kelly
Telephone:
+353 12158100
E-mail:
karl.kelly@nibrt.ie
NUTS code:
IE061 -
Dublin
Main address:
www.nibrt.ie
Address of the buyer profile:
https://irl.eu-supply.com/ctm/Company/CompanyInformation/Index/470
I.3)
Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at:
http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=215254&B=ETENDERS_SIMPLEAdditional information can be obtained from
the abovementioned address:
Tenders or requests to participate must be submitted
electronically via:
http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=215254&B=ETENDERS_SIMPLE
Tenders or requests to participate must be submitted
to the abovementioned address
I.4)
Type of the contracting authority
Body governed by public law
I.5)
Main activity
Education
Section II: Object
II.1)
Scope of the procurement
II.1.1)
Title
A single cell platform for T-Cell therapy development
Reference number:
PR22-013
II.1.2)
Main CPV code
38000000
-
Laboratory, optical and precision equipments (excl. glasses)
II.1.3)
Type of contract
Supplies
II.1.4)
Short description
NIBRT is looking to procure an instrument for cell therapy development applications. The desired platform is one that supports the rapid development of assays using single cells to enable exploration of cell therapy features, including but not limited to, screening of chimeric antigen receptor T cell constructs, discovery of T cell receptors or antigens, or exploration of regulatory T cell functions. The instrumental capabilities will be used by NIBRT as part of their current expansion and diversification to support all aspects of advanced therapy development and manufacture. The proposed instrument will be used to further our understanding of T cell immunotherapies through exploration of their phenotype, function and genotype.
II.1.5)
Estimated total value
Value excluding VAT: 650000.00
EUR
II.1.6)
Information about lots
This contract is divided into lots:
no
II.2)
Description
II.2.2)
Additional CPV code(s)
38000000
-
Laboratory, optical and precision equipments (excl. glasses)
II.2.3)
Place of performance
NUTS code:
IE061 -
Dublin
Main site or place of performance:
National Institute For Bioprocessing Research and Training (NIBRT), Fosters Avenue, Mount Merrion, Blackrock, Co. Dublin
II.2.4)
Description of the procurement
NIBRT is looking to procure an instrument for cell therapy development applications. The desired platform is one that supports the rapid development of assays using single cells to enable exploration of cell therapy features, including but not limited to, screening of chimeric antigen receptor T cell constructs, discovery of T cell receptors or antigens, or exploration of regulatory T cell functions. The instrumental capabilities will be used by NIBRT as part of their current expansion and diversification to support all aspects of advanced therapy development and manufacture. The proposed instrument will be used to further our understanding of T cell immunotherapies through exploration of their phenotype, function and genotype.
II.2.5)
Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)
Estimated value
Value excluding VAT: 650000.00
EUR
II.2.7)
Duration of the contract, framework agreement or dynamic purchasing system
Duration in months:
12
This contract is subject to renewal:
no
II.2.10)
Information about variants
Variants will be accepted:
no
II.2.11)
Information about options
Options:
no
II.2.13)
Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
no
Section III: Legal, economic, financial and technical information
III.1)
Conditions for participation
III.1.2)
Economic and financial standing
Selection criteria as stated in the procurement documents
III.1.3)
Technical and professional ability
Selection criteria as stated in the procurement documents
III.2)
Conditions related to the contract
Section IV: Procedure
IV.1)
Description
IV.1.1)
Type of procedure
Open procedure
IV.1.8)
Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement
: yes
IV.2)
Administrative information
IV.2.2)
Time limit for receipt of tenders or requests to participate
Date:
27/06/2022
Local time:
17:00
IV.2.4)
Languages in which tenders or requests to participate may be submitted
English
IV.2.7)
Conditions for opening of tenders
Date:
27/06/2022
Local time:
17:00
Section VI: Complementary information
VI.1)
Information about recurrence
This is a recurrent procurement:
no
VI.4)
Procedures for review
VI.4.1)